Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models

• Hoofdauteurs: Giovanna Castoldi (Auteur), Raffaella Carletti (Auteur), Francesca Barzaghi (Auteur), Michela Meani (Auteur), Giovanni Zatti (Auteur), Gianluca Perseghin (Auteur), Cira R. T. Di Gioia (Auteur), Gianpaolo Zerbini (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2024-03-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of glucose-lowering agents widely used for the treatment of type 2 diabetes mellitus. A number of clinical trials in type 2 diabetic patients with different degrees of renal impairment have clearly demonstrated that SGLT2 inhibitors reduc...